Atlas Trials

Evaluation of the Impact of Medium-chain Fatty Acids in the Evolution of Newly Diagnosed Mild Cognitive Impairment

Clinical trial NCT06951932 · RECRUITING

Trial details

NCT number
NCT06951932
Sponsor
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Mild Cognitive Impairment (MCI)
Start date
2024-07-03
Primary completion
2025-07-03
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.